Folic Acid vs Methylfolate: One of Them Needs Your Liver's Permission First

The Oasis Health Journal · Submitted July 20, 2026 · 8:23 PM ET

There are two folates on the shelf and they are wearing the same nametag.

One is folic acid. It is synthetic, it is fully oxidized, and it has been in almost every multivitamin since January 1998, which is when the FDA started requiring manufacturers to add 140 mcg of it per 100 g of enriched bread, cereal, flour, corn meal, pasta and rice. The other is 5-MTHF, sold as methylfolate or L-methylfolate, and it costs more. People assume the price gap is branding. It is a metabolic step.

Folic acid is not the form your blood actually runs on. The main form of folate in human plasma is 5-MTHF. So folic acid has to be converted, and the enzyme that starts that conversion is dihydrofolate reductase, or DHFR. Methylfolate does not need that step. It arrives already dressed for the occasion.

The bottleneck nobody advertises

In 2009, Bailey and Ayling measured DHFR activity in human liver taken from organ donors and from surgery. The result was not flattering. Per gram of tissue, at physiological pH, human liver reduced folic acid at less than 2 percent of the rate seen in rat liver. Across the human samples the activity varied about fivefold. So the conversion step is slow, and how slow depends on which human you happen to be.

Exceed that capacity and the leftover shows up intact in your bloodstream as unmetabolized folic acid, or UMFA. The NIH Office of Dietary Supplements notes that single doses of 300 or 400 mcg of folic acid, which is one ordinary supplement serving or one bowl of fortified cereal, produce detectable serum UMFA, while doses of 100 or 200 mcg do not. There is also a frequency wrinkle: smaller amounts taken more often produce higher UMFA than the same total taken in larger, less frequent doses. Which is the opposite of how everyone assumes dosing works.

Here is the honest part. ODS states plainly that whether UMFA has any biological activity, or works as a marker of anything at all, is not known. It has been linked to reduced numbers and activity of natural killer cells, and some researchers have floated a connection to cognition in older adults. ODS calls these potential consequences not well understood and in need of further research. Nobody has demonstrated that UMFA harms you. It is a flag, not a verdict.

What happens when you race them

In a 24-week trial published in the American Journal of Clinical Nutrition, 144 healthy women aged 19 to 33 took 400 mcg of folic acid daily, an equimolar 416 mcg of 6S-5-MTHF, 208 mcg of 6S-5-MTHF, or placebo. Red blood cell folate rose significantly more in the 416 mcg 5-MTHF group than in the folic acid group, at P less than 0.001. ODS summarizes the wider literature the same way: the bioavailability of 5-MTHF in supplements is the same as or greater than that of folic acid.

A 24-week randomized trial published in Frontiers in Nutrition in March 2026 moved the question into pregnancy. Eighty pregnant participants in Brooklyn were randomized to a prenatal multivitamin providing 1,000 mcg DFE of 6S-5-MTHF or one providing 1,330 mcg DFE of folic acid, and 62 finished. By week 24, detectable UMFA appeared in 7 percent of the methylfolate group versus 31 percent of the folic acid group (p = 0.013). Placental UMFA was lower as well. Serum total folate did not differ between the groups, even though the folic acid arm was taking 330 mcg DFE more.

That trial was funded by the supplement company Ritual, four of its authors were employed by Ritual, and the methylfolate arm used Ritual's own prenatal. The comparator was an unnamed standard prenatal that also differed in other B vitamins, choline and vitamin D. The finding is interesting. It is not disinterested.

Then the plot turns

The usual sales pitch for methylfolate is MTHFR. Roughly 25 percent of Hispanic people, 10 percent of white and Asian people, and 1 percent of Black people in the US carry two copies of the 677C to T variant, which leaves the MTHFR enzyme less active.

The CDC's position is blunt: people with an MTHFR gene variant can process all types of folate, including folic acid. At the same intake, people with the 677 TT genotype average only about 16 percent less folate in their blood than people with CC. Your folic acid intake matters more than your genotype for determining blood folate. The 2026 pregnancy trial found the same thing, with C677T producing no difference in 5-MTHF or total folate at any timepoint.

And there is the part the aisle skips. Folic acid is the only form of folate shown to help prevent neural tube defects. Every trial in that evidence base used folic acid. If pregnancy is possible, CDC and the US Preventive Services Task Force still say 400 mcg of folic acid daily, MTHFR variant or not. That is not the place to run a personal experiment on molecular forms.

Two traps printed right on the label

First, the two numbers are not as comparable as they look. Folate is listed in mcg DFE, where 1 mcg DFE equals 0.6 mcg of folic acid taken with food. Conversion factors for 5-MTHF have never been formally established, and the FDA lets manufacturers use 1.7 or their own factor so long as it does not exceed 1.7. Two bottles both reading 1,000 mcg DFE can hold different amounts of different molecules. The label is a translation, not a measurement.

Second, the tolerable upper limit of 1,000 mcg for adults applies to synthetic folate from supplements and fortified food, and it is stated in mcg, not mcg DFE. High folate intake can correct the anemia caused by a B12 deficiency while the nerve damage keeps going quietly in the background. Which is why folate and B12 belong in the same conversation, and why most sensible B complex formulas carry both.

Methylated B vitamins are not the most stable molecules in the cabinet. That is the boring reason we source professional-grade stock fresh per order instead of keeping it warehoused for a year. It makes our shipping slower than you would like and our potency higher than the alternative, and we have made peace with that trade.

The short version: methylfolate reliably gets folate into your blood and leaves less unmetabolized folic acid behind. Folic acid holds the one outcome that was actually measured in babies. Those are two different accomplishments, and the supplement aisle keeps presenting them as the same trophy.

This article is for education only and is not medical advice. Talk with your clinician before starting or changing any supplement, particularly during pregnancy or if you take methotrexate or antiseizure medication.

Sources

1. NIH Office of Dietary Supplements, Folate: Fact Sheet for Health Professionals
2. Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. PNAS. 2009;106(36):15424-15429
3. Lamers Y, et al. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. American Journal of Clinical Nutrition
4. Draicchio F, et al. Using 6S-5-methyltetrahydrofolate instead of folic acid in prenatal multivitamin reduces unmetabolized folic acid concentrations in the mother-fetus dyad: a 24-week randomized controlled trial. Frontiers in Nutrition. 2026;13:1679067
5. CDC, MTHFR Gene Variant and Folic Acid Facts
6. CDC, Folic Acid: Sources and Recommended Intake
7. l-5-Methyltetrahydrofolate Supplementation Increases Blood Folate Concentrations to a Greater Extent than Folic Acid Supplementation in Malaysian Women. The Journal of Nutrition